Bioconversion variation of ginsenoside CK mediated by human gut microbiota from healthy volunteers and colorectal cancer patients
Abstract Background Ginsenoside CK (GCK) serves as the potential anti-colorectal cancer (CRC) protopanaxadiol (PPD)-type saponin, which could be mainly bio-converted to yield PPD by gut microbiota. Meanwhile, the anti-CRC effects of GCK could be altered by gut microbiota due to their different diver...
Saved in:
Main Authors: | Yin-Ping Guo (Author), Li Shao (Author), Li Wang (Author), Man-Yun Chen (Author), Wei Zhang (Author), Wei-Hua Huang (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Personalized bioconversion of Panax notoginseng saponins mediated by gut microbiota between two different diet-pattern healthy subjects
by: Li Wang, et al.
Published: (2021) -
Effect of ginsenoside compound K on alleviating colitis via modulating gut microbiota
by: Li Wang, et al.
Published: (2022) -
Bioconversion Processes
by: Christian Kennes (Ed.)
Published: (2018) -
Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its Complications
by: Tongxi Zhuang, et al.
Published: (2021) -
Pretreatment and Bioconversion of Crop Residues
Published: (2021)